Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 5, 1990
Grant Date -
N/A
app pub date -
Feb 15, 1989
filing date -
Feb 15, 1989
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Zofenopril, fosinopril, (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-oxohexyl]-L-proline or a pharmaceutically acceptable salt thereof alone or in combination with a thrombolytic, antiarrhythmic, or antifibrillatory agent is employed to reduce pre- and post- ischemic myocardial arrhythmias and fibrillations as well as reducing arrhythmias associated with congestive heart failure.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully